The function of p53 correlates with its`wildtype' conformation, speci®cally recognized by antibodies PAb1620 and PAb246, and many cancer-associated mutations cause loss of this conformation. The epitopes of these antibodies were identi®ed using hybrid p53 proteins created by a new method. Plasmids carrying homologous genes cut at appropriate sites recombined eciently when transformed into RecE + E. coli. PAb1620 and PAb246 recognize mouse but not chicken p53; we created mouse ± chicken hybrids of the p53 core domain and tested antibody reactivity. PAb246 binding mapped to residues 201 ± 212, while PAb1620 required both residues 145 ± 157 and 201 ± 212 (human p53 numbering used throughout). An alanine-scan showed that the key residues for PAb246 and PAb1620 are completely distinct: PAb246 recognizes residues 202 ± 204 (Tyr-Pro-Glu) while PAb1620 recognizes residues Arg156, Leu206, Arg209, and Gln/Asn210, the last two residues being essential. Both antibody epitopes are far from the p53 interface with DNA, but near the epitope of the`mutant' conformation antibody PAb240. These epitope locations may help in dissecting the interactions of p53, including those with E6/E6-AP and in its DNAbound state. Oncogene (2001) 20, 2318 ± 2324.
Keywords: p53 conformation; epitope mapping; recombination; p53-DNA interaction p53 is a transcription factor that responds to cellular stresses, such as DNA damage, by promoting cell-cycle arrest and apoptosis (reviewed by Levine, 1997) . Mutations in p53 are the most common genetic alterations known in cancer (reviewed by Hainaut et al., 1998) . The vast majority are missense mutations within the central core domain that mediates sequencespeci®c binding to DNA.
p53 mutations often cause a change from thè wildtype' conformation to a`mutant' conformation that can be detected by monoclonal antibodies (MAbs) binding to the core domain. PAb1620 and PAb246 are speci®c for the`wildtype' conformation (Cook and Milner, 1990 ) and do not bind denatured p53. Conversely, PAb240 and several other antibodies bind to p53 in the`mutant' conformation and also to denatured p53 (Gannon et al., 1990; Legros et al., 1994b; Vojtesek et al., 1995) . Drugs restoring`wildtype' conformation and function to mutant p53 could induce tumor growth arrest and apoptosis; lead compounds have been identi®ed using a highthroughput screen for stabilization of the PAb1620 epitope against thermal denaturation (Foster et al., 1999) .
Full-length p53 is a tetramer, while the core domain is a monomer but binds as a tetramer to DNA (Balagurumoorthy et al., 1995; Wang et al., 1995) . The existing crystal structure shows only one core domain speci®cally bound to DNA (Cho et al., 1994) , so we do not have a direct picture of these higher-order interactions. PAb1620 and PAb246 have eects on the p53-DNA interaction; these could be interpreted structurally once their epitopes are known.
The PAb1620 and PAb246 epitopes could not be localized using sets of short synthetic peptides covering all of mouse and human p53 (Legros et al., 1994a; Lane et al., 1996) . Other epitope mapping attempts (Wade-Evans and Jenkins, 1985; Ravera et al., 1998) also did not evaluate epitopes in the context of a folded core domain. Our strategy for mapping the epitopes took advantage of the speciesspeci®city of the antibodies: both PAb1620 and PAb246 bind mouse p53 but not chicken p53 (PAb1620 also binds human p53). We used a rapid recombination method to generate inter-species hybrids of the p53 core domain. Hybrid proteins should maintain the same overall folding but display dierent surface residues, and correspondingly dier in their antibody reactivity. After epitopes were mapped to small regions of sequence, they were de®ned further by alanine-scanning mutagenesis. We discuss the implications of the location of these epitopes.
Recombination of homologous genes
A powerful way to generate hybrid genes is by homologous recombination (reviewed by Wang, 2001) . We have developed a simple method in E. coli that generates hybrids at high frequency and does not require any special plasmid construction; hybrids can easily be recombined again to make more complex hybrids. Preliminary studies showed that two factors were important for ecient recombination between cotransformed plasmids: the plasmids must have doublestrand breaks, and the host bacteria must have an active RecE recombination pathway (Kolodner et al., 1994) . Most colonies arising after such transformations were recombinants (data not shown).
We tested recombination between the core domains of several homologs: human, mouse, and chicken p53, and human p73 (Kaghad et al., 1997) . Human and mouse p53 core domains are the most closely related (83% nucleotide identity), while p73 is the most distant from the others (56 ± 58% identity). The plasmids were cut to give fragments with homologous ends (Figure 1 ). To regenerate a circular plasmid from these fragments, two crossovers are required, one of which must be within the p53 homologs.
Cut plasmids were co-transformed into RecE + bacteria in all combinations. Transformation with a single plasmid gave no or very few background colonies ( Figure 1 ,`buer' row and column). As expected, recombinations between identical genes gave the most colonies; however, even distant homologs like human p53 and p73 also recombined. Many dierent crossovers occurred, as seen below. Inactivating mismatch repair (mutS) did not improve recombination frequencies but did change the distribution of crossovers (data not shown).
A variety of DNA fragments will recombine when co-transformed, so long as homologous ends are present (data not shown). Recombination occurs eciently even if each plasmid has only a single cut (e.g., one at BamHI and the other at EcoRI); this is useful when the plasmids do not have suitable second restriction sites. Many hybrids used below were derived from such recombinations. As another example, cotransformation of three PCR-generated fragments gave recombinants resulting from three crossovers.
Mapping p53 epitopes using mouse ± chicken hybrids
We recombined mouse and chicken core domains to generate mouse/chicken and chicken/mouse hybrids ( Figure 2 ). Clones with distinct restriction ®ngerprints were sequenced to determine crossover points; all hybrids had a single crossover event. No point mutations were seen in over 30 hybrids sequenced. In the following, the residue numbering of human p53 is used for all sequences regardless of species. (Conversions can be made using Figure 3b .) Crossovers are identi®ed at the DNA level, but are numbered by the most N-terminal residue in the crossover interval.
Hybrid proteins were expressed directly from recombinants as GST fusions. Antibody reactivity was assayed by ELISA at low temperature, since the core domain is of marginal stability (Bullock et al., 1997) . Under these conditions, all proteins maintained the`wildtype' conformation (no binding by PAb240); while heating revealed the PAb240 epitope. As expected, PAb1620 and PAb246 bound mouse but not chicken p53 core domain. It has been suggested that the PAb1620 epitope requires p53 oligomerization (StuÈ rzbecher et al., 1992; Hansen et al., 1998) . We evaluated this using our ELISA. Puri®ed monomeric human core domain (Bullock et al., 1997 ; gift of P Nikolova) inhibited PAb1620 binding to immobilized GST-mouse core domain (50% inhibitory concentration=15 mM), implying that PAb1620 can recognize monomeric p53 core domain.
In the mouse/chicken series of hybrids, both PAb246 and PAb1620 bound hybrid m5 but not m6, implicat- Above is a schematic of glutathione S-transferase (GST) fusion plasmids, identical except for the genes of interest (here p53 homologs). One is cut at EcoRI+PstI sites, the other at BamHI+EcoRV sites. Only if fragments recombine both within the BamHI ± EcoRI interval and the EcoRV ± PstI interval do they regenerate a circular plasmid (follow the thick lines). Irrelevant fragments are shown by dotted lines. Below are the number of ampicillin-resistant colonies produced after co-transformation using 60 ng of each cut plasmid or buer control; recombinations between identical genes are in italics. (The mouse p53 plasmid was cut at the nearby AhdI site instead of PstI, as it does not have a unique PstI site.) Methods: Core domains of mouse p53 (residues 88 ± 306), chicken p53 (residues 80 ± 293), and human p73 (residues 105 ± 333) were PCRampli®ed from cDNA and the p73 EcoRI site mutated; human core domain DNA (residues 90 ± 312) was from Bullock et al., 1997 . Fragments were ligated into the BamHI+EcoRI sites of the vector pGEX-4T-1 (Pharmacia). For recombination, plasmids were cut with restriction enzymes and puri®ed with QIAquick columns (QIAGEN) or phenol-chloroform/precipitation. DNA (30 ± 1000 ng of each) was co-transformed (Chung et al., 1989) into strain JC8679 (E. coli Genetic Stock Center; Gillen et al., 1981) . When plasmids were cut with only one enzyme, they were also phosphatased to reduce background from re-ligation. Colonies were screened by restriction enzyme ®ngerprinting (typically with MspI) of PCR products, and most gave band patterns dierent from both parents Oncogene p53`wildtype' conformation epitopes PL Wang et al ing residues 180 ± 219. In the chicken/mouse series, PAb246 bound c6 but not c5, implicating a similar region, residues 195 ± 220. PAb1620 bound c9 strongly, c6 ± c8 weakly, and c5 not at all; this suggests that while residues 195 ± 220 confer some PAb1620 binding (c5 vs c6), full reactivity also requires residues 143 ± 157 (c8 vs c9). We made more complex hybrids to determine if the implicated regions are both necessary and sucient. These were made by recombining genes cut at new sites (hybrid x8 was made by crossing chicken p53 with mouse p53 cut internally by NcoI) and recombining hybrids with each other (hybrid x1 was made by crossing c6 and m5).
PAb246 did not bind hybrid x7, which is mouse except at 180 ± 241, indicating that those residues are necessary for binding. Similarly, PAb1620 bound neither x7 nor x8, indicating that residues 140 ± 180 and 180 ± 241 are necessary. PAb246 bound hybrid x1, which only has mouse residues from 195 ± 223, so these are sucient to allow recognition; likewise, PAb1620 bound hybrid x9, so residues 143 ± 157 plus 194 ± 220 are sucient. These minimal mouse regions confer binding to a chicken scaold, but not full reactivity. Larger stretches of mouse sequence can improve binding, presumably by conferring additional direct contacts or allowing better packing of the minimal mouse regions.
The regions de®ned by the minimal hybrids are residues 195 ± 223 for PAb246, and residues 143 ± 157 and 194 ± 220 for PAb1620. The crossovers were de®ned by dierences at the DNA level; at the amino acid level, some of the included residues are identical between mouse and chicken. Taking this into account, the epitopes can be narrowed to 201 ± 212 for PAb246, and 145 ± 157 and 201 ± 212 for PAb1620 (underlined in black, Figure 3b ).
Alanine-scan of minimal epitope regions
We next made alanine mutants of polymorphic residues in the minimal regions and tested antibody reactivity (Figure 3a) . Although both PAb246 and PAb1620 required residues 201 ± 212, their ®ne speci®-cities were quite dierent. PAb246 binding was decreased by single mutations of Tyr202 or Pro203, and abolished by double mutations of residue 203 plus either 202 or 204. PAb1620 binding was decreased by mutation of Arg156 or Leu206, and was abolished by mutation of Arg209 or Gln210. Mutations that aected Figure 2 Antibody reactivity of p53 hybrids. Proteins are shown as rectangles, black or white indicating mouse or chicken p53 sequence, respectively. Numbering is shown by a ruler below each set; each crossover location is notated. Hybrid names are on the left and reactivity with PAb246 or PAb1620 (ELISA signal as a percentage of mouse core domain ELISA signal, normalized for fusion protein levels using the ELISA signal for GST) is on the right, using the symbols in the key. Methods: p53 hybrids were generated by recombination as in Figure 1 . Proteins were expressed by inoculating saturated cultures 1 : 100 into 10 ml 26TY+100 mg/ml ampicillin, shaking at 378C until OD 600 *1, then shaking at 208C overnight (soluble protein yields were better when IPTG induction was omitted). Bacteria were resuspended in 1 ml ice-cold buer (50 mM Tris pH 7.2, 5 mM dithiothreitol (DTT), 200 mM phenylmethylsulfonyl¯uoride), freeze ± thawed, sonicated on ice, and insoluble material removed by centrifugation. ELISA plates were coated with 5 mg/ml goat anti-GST (Pharmacia) in phosphate-buered saline (PBS) and blocked with MPBS (PBS, 3% nonfat dry milk (Marvel), 2% BSA). Reagents were diluted in MPBS+2 mM DTT. The following incubations were done on ice for 2 h : (1) bacterial extracts, diluted 1 : 5; (2) MAbs, diluted 1 : 100 ± 200 (PAb240 and PAb1620 from Alan Fersht's lab, PAb246 from Calbiochem); (3) peroxidase-conjugated anti-mouse IgG, diluted 1 : 2000 (Sigma #A2554). To compare fusion protein levels, incubations 2 and 3 were replaced by an incubation with peroxidase-conjugated anti-GST, diluted 1 : 1000 (Sigma #A7340); bound GST levels were similar for most of the hybrids, and 490% of the GST was present as full-length fusion by Western blot. Each incubation was followed by three washes with cold PBS+2 mM DTT; at the end an additional three washes with cold PBS were done to remove DTT. The plate was developed with tetramethylbenzidine binding of PAb1620 did not aect binding of PAb246 and vice versa.
The key residues identi®ed by alanine-scan (boxed in Figure 3b ) are consistent with the species-speci®city of the antibodies. PAb246 binds mouse but not human p53, and its key residues 202 ± 204 are dierent in mouse and human (Tyr-Pro-Glu vs Arg-Val-Glu). PAb1620 binds both mouse and human p53, and its key residues 156, 206, 209, and 210 are identical in mouse and human except for a conservative dierence at 210 (Gln vs Asn). Neither antibody recognizes chicken p53, which diers from both human and mouse at all key residue positions. Hybrid mapping cannot exclude the possibility that residues conserved between mouse and chicken may also be important; but any such residues would be contiguous with the epitope surfaces we have de®ned.
Comparison to previous epitope mapping studies
Deletion mutants of mouse p53 have been used to map binding of PAb246 and several other MAbs (WadeEvans and Jenkins, 1985) . The PAb246 epitope was assigned to residues 92 ± 113 (gray underline, mouse sequence, Figure 3b ) because PAb246 immunoprecipitated N-terminal deletions up to residue 91 but not to 113. Deletion to 113 removes part of the core domain and abolishes DNA-binding activity . This region of mouse sequence does not confer PAb246 binding, and replacing with divergent chicken sequence does not decrease binding (m8 vs chicken; c9 vs mouse, Figure 2) .
Phage display has been used to select peptides binding to PAb1620 (Ravera et al., 1998) ; peptide competition with p53 was not demonstrated. Using sequence comparison of the peptides with core domain, the PAb1620 epitope was assigned to residues 106 ± 113 and 146 ± 156 (gray underline, human sequence, Figure 3b ). The second region is similar to one found by hybrid mapping; at its periphery is key residue 156. However, the essential residues 209 ± 210 were not identi®ed, and no PAb1620 binding is seen even if both regions are mouse sequence (hybrids m6 and x7, Figure 2) . Reactivity with PAb1620 and PAb246 is shown above and below the mutated residue in the mouse p53 sequence, using the symbols in the key. Double alanine mutations are marked by brackets. (b) Epitope locations in p53 sequences. The aligned sequences of human, mouse, and chicken p53 core domains are shown (identity to the human residue shown by a dash, gaps by a space). Items concerning PAb1620 or PAb246 are notated on the human or mouse sequence, respectively: regions identi®ed by hybrid mapping are underlined in black, while regions identi®ed by others are underlined with gray brackets; essential and non-essential key residues from alanine-scan are highlighted with black and gray boxes, respectively. Human p53 numbering (used throughout) is marked along the top; for reference, species-speci®c numberings are given at the sides. Above the sequences is the secondary structure of human p53 core domain (Cho et al., 1994) . Methods: Alanine mutations were introduced by PCR and veri®ed by DNA sequencing. Protein expression and ELISA were as in Figure 2 Antibody epitopes and the three-dimensional core domain structure Human p53 core domain is a sandwich of two twisted b-sheets, from which extend additional elements that contact DNA and coordinate a zinc ion (Figure 4) . The PAb1620 and PAb246 epitopes are both in the vicinity of strand S6; the two antibodies can compete for binding (Milner et al., 1987) . Both epitopes are distant from the DNA-binding interface. The locations of the two epitopes may have in part been dictated by the antigen used, SV40 virus-immortalized cells (Ball et al., 1984; Yewdell et al., 1986) ; SV40 large T antigen stabilizes p53 by binding to the core domain and masks its DNA-binding surface. This stabilization may have facilitated the generation of`wildtype' conformation antibodies, as immunization with puri®ed p53 gave only core domain antibodies against the denatured/ mutant' conformation (Legros et al., 1994b; Vojtesek et al., 1995) .
The PAb1620 key residues 156, 206, 209, and 210 de®ne an elongate surface region; the two most Figure 4 Three-dimensional locations of p53 epitopes. The main-chain ribbon and side-chains of key residues are shown. The PAb1620, PAb246, and PAb240 epitopes are blue, red, and violet, respectively; core domain N-and C-terminal residues (96 ± 97 and 288 ± 289) are green and cyan, respectively; DNA is blue-gray; and zinc is a dark gray ball. Methods: PDB entry 1TSR was drawn using MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merritt and Murphy, 1994) p53`wildtype' conformation epitopes PL Wang et al important residues, 209 and 210, are highly exposed on a tight turn between strands S6 and S7. The other two residues lie in a groove along the top of the core domain. Since PAb246 is mouse-speci®c, the human structure can only give us the general setting of its epitope: residues 202 and 203 are part of a turn between strands S5 and S6, and residue 204 is the beginning of strand S6. Both`wildtype' epitopes involve loops attached to one edge of the larger bsheet (strands S6-S7-S4-S9-S10), and may be quite sensitive to b-sheet perturbations. The epitope of thè mutant' conformation antibody PAb240 lies close by in strand S7 (residues 213-217; Stephen and Lane, 1992) . This region is hidden by strand S6 and neighboring loops, so that exposure of the`mutant' epitope and`wildtype' epitopes is mutually exclusive.
HPV E6 and the PAb246 epitope
Degradation of p53 is induced by the E6 protein of human papillomaviruses associated with cervical cancer (`high-risk' HPV-16 and HPV-18). E6 alone binds weakly to p53 but strongly when the cellular protein E6-AP is present (Li and Cono, 1996a) ; the E6/E6-AP complex ubiquitinates p53 and targets it for degradation by proteosomes (Schener et al., 1990; Huibregtse et al., 1991) . Degradation requires thè wildtype' conformation;`mutant' conformation p53 is not degraded (Medcalf and Milner, 1993) . PAb246 (but not PAb1620) inhibits E6-mediated degradation of mouse p53 (Medcalf and Milner, 1993; Li and Cono, 1996b) . However PAb246 does not block E6 binding to p53 (Molinari and Milner, 1995) , suggesting that the epitope de®ned here may be a region of contact with the E6/E6-AP complex.
The`wildtype' conformation and p53 DNA binding PAb1620 and PAb246 have been used previously to probe p53-DNA complexes; the results are complex and depend on many factors. In some cases, they cause disruption of p53-DNA complexes Hall and Milner, 1995; Wolkowicz et al., 1995; McLure and Lee, 1996) ; since the antibodies bind far from the DNA interface, disruption must be due to eects on interactions between subunits rather than on the interaction with DNA. Another interesting case is the lack of recognition by PAb1620 of full-length human p53-DNA complexes (Hupp et al., 1992; Hall and Milner, 1995; Cohen et al., 1999) , even though PAb1620 recognizes free fulllength human p53 (Cook and Milner, 1990 ) and disrupts human core-DNA complexes (Hansen et al., 1998) . The crystal structures of the core domain whether free, bound to DNA, or bound to another protein (Cho et al., 1994; Gorina and Pavletich, 1996) do not show signi®cant conformational dierences; therefore the simplest explanation for the loss of the PAb1620 epitope is masking by other parts of p53. The PAb1620 epitope is near the core domain N-terminus and distant from its C-terminus (Figure 4) , suggesting that the N-terminal region can mask the PAb1620 epitope in the full-length complex. Consistent with this, human residues 80 ± 93 (just N-terminal to the core domain) are a`negative regulatory region' that may change interactions upon activation of DNA binding (MuÈ ller-Tiemann et al., 1998) . Changes in N-terminal region con®guration could modulate transactivation and interactions with other proteins.
The PAb1620 epitope is present on mouse p53-DNA complexes (Hall and Milner, 1995) , in contrast to human complexes; also, the mouse N-terminal region does not have negative regulatory function (Hansen et al., 1998) . This suggests functional dierences between human and mouse N-terminal regions, the most evolutionarily divergent part of p53 (reviewed by Soussi and May, 1996) , and may allow these phenomena to be dissected using p53 hybrids involving the N-terminal region.
